Similar articles

• [GnRH-analogs in the therapy of uterine myomatosis].

  Wieacker P, Geisthövel F, Adelberger V, Breckwoldt M. Wieacker P, et al. Ther Umsch. 1990 Dec;47(12):951-7. Ther Umsch. 1990. PMID: 2151405 Clinical Trial. German.
• Gonadotropin-releasing hormone specific binding sites in uterine leiomyomata.

  Wiznitzer A, Marbach M, Hazum E, Insler V, Sharoni Y, Levy J. Wiznitzer A, et al. Biochem Biophys Res Commun. 1988 May 16;152(3):1326-31. doi: 10.1016/s0006-291x(88)80430-3. Biochem Biophys Res Commun. 1988. PMID: 2837183
• Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy.

  Kuhlmann M, Gärtner A, Schindler EM, Regidor PA, Bühler K, Schindler AE. Kuhlmann M, et al. Gynecol Endocrinol. 1997 Jun;11(3):169-74. doi: 10.3109/09513599709152531. Gynecol Endocrinol. 1997. PMID: 9209897
• [GnRH antagonist].

  Yano T, Taketani Y. Yano T, et al. Nihon Rinsho. 2001 Jan;59 Suppl 1:133-8. Nihon Rinsho. 2001. PMID: 11235152 Review. Japanese. No abstract available.
• Hormonal therapy before surgical treatment for uterine leiomyomas.

  Moghissi KS. Moghissi KS. Surg Gynecol Obstet. 1991 Jun;172(6):497-502. Surg Gynecol Obstet. 1991. PMID: 1827931 Review.